Last reviewed · How we verify

NCT04694677

Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.

Status unknown NA Last updated 5 January 2021
What this trial tests

NA trial testing women receiving tranexamic acid in Myoma in 60 participants. Status unknown.

Timeline
10 January 2021
Primary endpoint
15 August 2021
10 September 2021

Quick facts

Lead sponsorAljazeera Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment60
Start date10 January 2021
Primary completion15 August 2021
Estimated completion10 September 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Aljazeera Hospital

Who can join

Adults 20 to 50, female only, with Myoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Uterine leiomyomas (fibroids) are the most common benign tumors among women . Fibroids are found in approximately 15% to 30% of women in the reproductive age group

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myoma

Currently open trials in the same condition.

Other Aljazeera Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04694677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing